In the meta-analysis, treatment effect (GLP-1RA vs placebo) on CV outcomes was no different with vs without baseline metformin (overall ratio between the hazard ratios for metformin vs no-metformin 1.09 [0.96;1.22])
Frequently Asked Questions What is glutathione and why is it important in Parkinson's disease
The study indicates that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of the lean mass loss typically associated with GLP-1 therapy, while increasing fat loss
References : [1] [3] [4] [5] [6] National Library of Medicine, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data, Pickart, L., Margolina, A., July 2018 [2] National LIbrary of Medicine, The potential of GHK as an anti-aging peptide, Dou, Y., Lee, A., Zhu, L., Morton, J., Ladiges, W., March 2020